论文标题
用于尿路感染筛查的无镜头全息成像
Lens free holographic imaging for urinary tract infection screening
论文作者
论文摘要
尿路感染(UTI)是一种常见状况,可能导致严重的并发症,包括肾脏损伤,精神状况改变,败血症和死亡。尿液分析和尿液培养等实验室测试是UTI诊断的主要主体,从而收集并处理尿液标本以揭示其细胞和化学成分。此过程需要精确的标本收集,处理感染性人体废物,受控尿液储存以及及时运输到现代实验室设备进行分析。无全息透镜成像(LFI)可以通过简单且紧凑的光学设置测量大量尿液,有可能在患者的床旁进行自动尿液分析。我们引入了一个LFI系统,能够解决重要的尿液临床生物标志物,例如红细胞,白细胞,晶体,铸造和大肠杆菌。这种方法对检测几种临床尿液异常(例如血尿,脓尿和杆菌)相关的颗粒浓度敏感。我们显示,可以通过分析LFI测量值来估算八个数量级的细菌浓度。血细胞浓度的LFI测量对细菌浓度的变化的七个数量级的变化相对不敏感。最后,LFI揭示了人类患者的UTI阳性和UTI阴性尿液之间的明显差异。这些结果共同表明了LFI作为尿液筛查的工具的希望,有可能提早对UTI和其他病理过程的预防点检测。
Urinary tract infections (UTIs) are a common condition that can lead to serious complications including kidney injury, altered mental status, sepsis, and death. Laboratory tests such as urinalysis and urine culture are the mainstays of UTI diagnosis, whereby a urine specimen is collected and processed to reveal its cellular and chemical composition. This process requires precise specimen collection, handling infectious human waste, controlled urine storage, and timely transportation to modern laboratory equipment for analysis. Holographic lens free imaging (LFI) can measure large volumes of urine via a simple and compact optical setup, potentially enabling automatic urine analysis at the patient bedside. We introduce an LFI system capable of resolving important urine clinical biomarkers such as red blood cells, white blood cells, crystals, casts, and E. Coli in urine phantoms. This approach is sensitive to the particulate concentrations relevant for detecting several clinical urine abnormalities such as hematuria, pyuria, and bacteriuria. We show bacteria concentrations across eight orders of magnitude can be estimated by analyzing LFI measurements. LFI measurements of blood cell concentrations are relatively insensitive to changes in bacteria concentrations of over seven orders of magnitude. Lastly, LFI reveals clear differences between UTI-positive and UTI-negative urine from human patients. Together, these results show promise for LFI as a tool for urine screening, potentially offering early, point-of-care detection of UTI and other pathological processes.